Table 2 Association of Rab25 protein expression with various clinicopathologic characteristics of 100 PCa patients
Clinical variables | High-Rab25 (n, %) | Low-Rab25 (n, %) | P |
|---|---|---|---|
Age (years) | |||
≤66 | 18 (47.4) | 20 (52.6) | NS |
>66 | 34 (54.8) | 28 (45.2) | |
Preoperative serum PSA levels (ng/ml) | |||
<4 | 10 (50.0) | 10 (50.0) | NS |
≥4 | 42 (52.5) | 38 (47.5) | |
Clinical stage | |||
T1 + T2 | 30 (57.7) | 22 (42.3) | NS |
T3 + T4 | 22 (45.8) | 26 (54.2) | |
Gleason score | |||
<7 | 16 (30.8) | 36 (69.2) | 0.01 |
≥7 | 36 (75.0) | 12 (25.0) | |
Metastasis | 0.01 | ||
Negative | 43 (47.8) | 47 (52.2) | |
Positive | 9 (90.0) | 1 (10.0) | |